Comparison of lenograstim and filgrastim: Effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 3, 2005, Pages 152-156

  Huttmann A ^a   Schirsafi, K ^a   Seeber, S ^a   Bojko, P ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b MVZ Elisenhof   (Germany)

Author keywords

Filgrastim; HDC; Lenograstim; PBSCT

Indexed keywords

ANTIINFECTIVE AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; TREOSULFAN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL; BODY WEIGHT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; INFORMATION PROCESSING; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OVARY CANCER; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYSICAL CHEMISTRY; PLASMACYTOMA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FILGRASTIM; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LENGTH OF STAY; LEUKOCYTES; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLATELET TRANSFUSION; RECOMBINANT PROTEINS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 12944308796     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0636-x     Document Type: Article

References (25)

1. Arakawa T, Prestrelski SJ, Narhi LO, Boone TC, Kenney WC (1993) Cysteine 17 of recombinant human granulocyte-colony stimulating factor is partially solvent-exposed. J Protein Chem 12:525-531
2. Baumann I, Testa NG, Lange C, de Wynter E, Luft T, Dexter TM, van Hoef ME, Howell A (1993) Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants. Lancet 341:369
3. + subsets during apheresis. J Cancer Res Clin Oncol 128:19-28
4. Bonig H, Silbermann S, Weller S, Kirschke R, Korholz D, Janssen G, Gobel U, Nurnberger W (2001) Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)-results of a prospective randomised monocentre study. Bone Marrow Transplant 28:259-264
5. Carter CR, Whitmore KM, Thorpe R (2004) The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation. J Leukoc Biol 75:512-522
6. Clogston CL, Hu S, Boone TC, Lu HS (1993) Glycosidase digestion, electrophoresis and chromatographic analysis of recombinant human granulocyte colony-stimulating factor glycoforms produced in Chinese hamster ovary cells. J Chromatogr 637:55-62
7. Common Terminology Criteria for Adverse Events. Cancer Therapy Evaluation Program (2003), Version 3.0. (http:// ctep.cancer.gov/reporting/ctc.html)
8. Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D (1988) Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074-2081
9. Esser M, Brunner H (2003) Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia. Pharmacoeconomics 21:1295-1313
10. Gisselbrecht C, Prentice HG, Bacigalupo A, Biron P, Milpied N, Rubie H, Cunningham D, Legros M, Pico JL, Linch DC (1994) Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet 343:696-700
11. Hoglund M, Smedmyr B, Simonsson B, Totterman T, Bengtsson M (1996) Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 18:19-27
12. Kim IH, Park SK, Suh OK, Oh JM (2003) Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose chemotherapy. Curr Med Res Opin 19:753-759
13. Kubota N, Orita T, Hattori K, Oh-eda M, Ochi N, Yamazaki T (1990) Structural characterization of natural and recombinant human granulocyte colony-stimulating factors. J Biochem 107:486-492
14. Mire-Sluis AR, Das RG, Thorpe R (1995) The international standard for granulocyte colony stimulating factor (G-CSF). Evaluation in an international collaborative study. Participants of the Collaborative Study. J Immunol Methods 179:117-126
15. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R (1988) Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1:667-672
16. Nissen C (1994) Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency. Eur J Cancer 30A [Suppl 3]:S12-S14
17. Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F (1997) Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats. Cancer Chemother Pharmacol 39:259-266
18. Oh-Eda M, Hasegawa M, Hattori K, Kuboniwa H, Kojima T, Orita T, Tomonou K, Yamazaki T, Ochi N (1990) O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity. J Biol Chem 265:11432-11435
19. Pedrazzoli P, Gibelli N, Pavesi L, Preti P, Piolini M, Bertolini F, Robustelli della CG (1996) Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells. Anticancer Res 16:1781-1785
20. Querol S, Cancelas JA, Amat L, Capmany G, Garcia J (1999) Effect of glycosylation of recombinant human granulocytic colony-stimulating factor on expansion cultures of umbilical cord blood CD34+ cells. Haematologica 84:493-498
21. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM (1989) Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891-895
22. Tanaka H, Tanaka Y, Shinagawa K, Yamagishi Y, Ohtaki K, Asano K (1997) Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys. Cytokine 9:360-369
23. Watts MJ, Addison I, Long SG, Hartley S, Warrington S, Boyce M, Linch DC (1997) Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers. Br J Haematol 98:474-479
24. Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G (1996) filgrastim (r-metHuG-CSF): the first 10 years. Blood 88:1907-1929
25. Zsebo KM, Cohen AM, Murdock DC, Boone TC, Inoue H, Chazin VR, Hines D, Souza LM (1986) Recombinant human granulocyte colony stimulating factor: molecular and biological characterization. Immunobiology 172:175-184